T
Todd E. DeFor
Researcher at University of Minnesota
Publications - 297
Citations - 19625
Todd E. DeFor is an academic researcher from University of Minnesota. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 64, co-authored 288 publications receiving 17856 citations. Previous affiliations of Todd E. DeFor include City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units
Claudio G. Brunstein,Juliet N. Barker,Daniel J. Weisdorf,Todd E. DeFor,David H. McKenna,S Y Chong,Jeffrey S. Miller,Philip B. McGlave,John E. Wagner +8 more
TL;DR: Despite safety of administration, IBMI of one of two UCB units did not shorten the time to neutrophil engraftment and offers no advantage over conventional double unit transplantation.
Journal ArticleDOI
Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.
Tracey A. O'Brien,Ted Eastlund,Charles Peters,Joseph P. Neglia,Todd E. DeFor,Norma K.C. Ramsay,K. Scott Baker +6 more
TL;DR: Mortality was high in this series of 19 patients with 10 dying following the onset of AIHA, three as a direct consequence of haemolysis, and the majority of patients demonstrating disease refractory to traditional steroid therapy.
Journal ArticleDOI
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
Juliet N. Barker,Paul L. Martin,James E. Coad,Todd E. DeFor,Michael E. Trigg,Joanne Kurtzberg,Daniel J. Weisdorf,John E. Wagner +7 more
TL;DR: The incidence of EBV-PTLD after unrelated-donor UCBT appears similar to that observed after transplantation using unrelated bone marrow (BM) and compares favorably with unrelated-Donor T-cell-depleted BM transplantation.
Journal ArticleDOI
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.
TL;DR: Patients with HR acute GVHD have a poor prognosis, require alternative initial therapy and should be the focus of novel therapeutic trials.
Journal ArticleDOI
Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation
J Beck,John E. Wagner,Todd E. DeFor,Claudio G. Brunstein,Mark R. Schleiss,Jo Anne H. Young,Daniel H. Weisdorf,Sarah Cooley,Jeffrey S. Miller,Michael R. Verneris +9 more
TL;DR: Although recipient CMV serostatus and CMV reactivation have little demonstrable impact on UCB transplant outcomes, the development of CMV disease remains a risk, associated with inferior outcomes.